Introducing GreenLight

An RNA platform to help feed the world and keep it healthy

Plant and Animal Health

Feeding the world: RNA for agriculture

We must grow more food with the same amount of land even as we honor the global desire—and increasing technical need—to replace chemical pesticides. While these pesticides face increasing consumer opposition and threat of outright bans due to environmental damage, many are losing their effectiveness.

Learn more

top down image of field

HUMAN HEALTH

Keeping the world healthy: messenger RNA for human health

Messenger RNA’s features make it broadly valuable for human health. It is well known that mRNA is being used to make effective Covid-19 vaccines that have been developed quickly—critical for pandemic response. GreenLight is working on multiple vaccine and therapeutic uses of mRNA.

Learn more

Our platform

Our platform and pipeline addressing agriculture and human health

This platform enables us to make complex biological molecules in a manner that we believe is capable of creating products at a lower cost, required quality, and in a more scalable fashion than alternative solutions.

Learn more

bee on flower

ESG COMMITMENT

ESG is core to our purpose

Our pipeline helps address some of the world’s biggest problems and we believe in doing the right thing to meet our environmental, social, and governance responsibilities.

Learn more

News and insights

The latest on GreenLight’s work and partnerships, and what the world has been saying about us.

All news
  • GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award

    05.10.22


    GreenLight’s honeybee-saving RNA solution named finalist in World Changing Ideas Award
    GO!
  • International crop network validates ledprona as a new Mode of Action group

    04.05.22


    International crop network validates ledprona as a new Mode of Action group
    GO!
  • Co-developer of COVID-19 Vaccine Joins GreenLight Advisory Board

    03.29.22


    Co-developer of COVID-19 Vaccine Joins GreenLight Advisory Board
    GO!
  • EndPoints: Q&A with GreenLight CEO Andrey Zarur

    03.17.22


    EndPoints: Q&A with GreenLight CEO Andrey Zarur
    GO!
  • BioCentury: GreenLight messenger RNA shingles vaccine deal with Serum Institute of India

    03.14.22


    BioCentury: GreenLight messenger RNA shingles vaccine deal with Serum Institute of India
    GO!
  • Endpoints: GreenLight licenses mRNA shingles vaccine

    03.14.22


    Endpoints: GreenLight licenses mRNA shingles vaccine
    GO!